140 related articles for article (PubMed ID: 1925472)
1. [Antimycotic therapy in clinical practice].
Schaffner A
Schweiz Med Wochenschr; 1991 Sep; 121(39):1413-8. PubMed ID: 1925472
[TBL] [Abstract][Full Text] [Related]
2. Current concepts in systemic and topical therapy for superficial mycoses.
Millikan LE
Clin Dermatol; 2010 Mar; 28(2):212-6. PubMed ID: 20347665
[TBL] [Abstract][Full Text] [Related]
3. [New antifungal agents in the treatment of superficial dermatomycoses].
Degreef H
Ann Dermatol Venereol; 1993; 120(1):21-31. PubMed ID: 8393313
[TBL] [Abstract][Full Text] [Related]
4. The use of systemic antimycotics in dermatotherapy.
Niewerth M; Korting HC
Eur J Dermatol; 2000 Mar; 10(2):155-60. PubMed ID: 10694319
[TBL] [Abstract][Full Text] [Related]
5. [Antimycotic therapy].
Schaffner A
Ther Umsch; 1990 Aug; 47(8):664-9. PubMed ID: 2218968
[TBL] [Abstract][Full Text] [Related]
6. [Fungal infections in primary care].
Schaffner A
Praxis (Bern 1994); 1996 Oct; 85(40):1236-9. PubMed ID: 8966412
[TBL] [Abstract][Full Text] [Related]
7. Discovering antimycotic drugs: today and tomorrow.
Jacobs PH; Nall L
Cutis; 1990 Apr; 45(4):245-50. PubMed ID: 2158417
[No Abstract] [Full Text] [Related]
8. Current drug therapy of systemic mycoses: a review.
Yonga G
East Afr Med J; 1995 Jun; 72(6):394-8. PubMed ID: 7498014
[TBL] [Abstract][Full Text] [Related]
9. Oral itraconazole therapy for superficial, subcutaneous, and systemic infections. A panoramic view.
De Rosso JQ; Gupta AK
Postgrad Med; 1999 Jul; Spec No():46-52. PubMed ID: 10492666
[TBL] [Abstract][Full Text] [Related]
10. Treatment of systemic mycoses in patients with AIDS.
Graybill JR
Arch Med Res; 1993; 24(4):403-12. PubMed ID: 8118165
[TBL] [Abstract][Full Text] [Related]
11. Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity.
Schmid-Wendtner MH; Korting HC
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1013-8. PubMed ID: 17714119
[TBL] [Abstract][Full Text] [Related]
12. Mycology - an update Part 3: Dermatomycoses: topical and systemic therapy.
Nenoff P; Krüger C; Paasch U; Ginter-Hanselmayer G
J Dtsch Dermatol Ges; 2015 May; 13(5):387-410; quiz 411. PubMed ID: 25918080
[TBL] [Abstract][Full Text] [Related]
13. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
[TBL] [Abstract][Full Text] [Related]
14. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.
Rautemaa R; Richardson M; Pfaller MA; Perheentupa J; Saxén H
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):182-5. PubMed ID: 18597968
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
Fehér J; Lengyel G
Orv Hetil; 2003 Aug; 144(34):1677-82. PubMed ID: 14528841
[TBL] [Abstract][Full Text] [Related]
16. Superficial fungal infections in children and adolescents.
Rudy SJ
Nurse Pract Forum; 1999 Jun; 10(2):56-66. PubMed ID: 10542582
[TBL] [Abstract][Full Text] [Related]
17. [Future directions of antimycotic therapy].
Meunier F
Mycoses; 1994; 37 Suppl 2():77-82. PubMed ID: 7541893
[TBL] [Abstract][Full Text] [Related]
18. [Therapy of candidiasis and cryptococcosis in AIDS].
Just-Nübling G
Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
[TBL] [Abstract][Full Text] [Related]
19. Ketoconazole: a major innovation for treatment of fungal disease.
Graybill JR; Drutz DJ; Murphy AL
Ann Intern Med; 1980 Dec; 93(6):921-3. PubMed ID: 6255850
[No Abstract] [Full Text] [Related]
20. [Clinical importance of azoles in antifungal therapy: treatment or prophylaxis with new azoles in hematology].
Vazquez Lopez L
Rev Esp Quimioter; 2004 Mar; 17(1):98-100. PubMed ID: 15201932
[No Abstract] [Full Text] [Related]
[Next] [New Search]
